MX2024006051A - Nuevos andamios de proteinas tale con relaciones de actividad en objetivo/fuera de objetivo mejoradas. - Google Patents

Nuevos andamios de proteinas tale con relaciones de actividad en objetivo/fuera de objetivo mejoradas.

Info

Publication number
MX2024006051A
MX2024006051A MX2024006051A MX2024006051A MX2024006051A MX 2024006051 A MX2024006051 A MX 2024006051A MX 2024006051 A MX2024006051 A MX 2024006051A MX 2024006051 A MX2024006051 A MX 2024006051A MX 2024006051 A MX2024006051 A MX 2024006051A
Authority
MX
Mexico
Prior art keywords
target
improved
activity ratios
tale protein
protein scaffolds
Prior art date
Application number
MX2024006051A
Other languages
English (en)
Spanish (es)
Inventor
Philippe Duchateau
Alexandre Juillerat
Alex Boyne
Selena Kazancioglu
Original Assignee
Cellectis Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectis Sa filed Critical Cellectis Sa
Publication of MX2024006051A publication Critical patent/MX2024006051A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2024006051A 2021-11-23 2022-11-23 Nuevos andamios de proteinas tale con relaciones de actividad en objetivo/fuera de objetivo mejoradas. MX2024006051A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163282453P 2021-11-23 2021-11-23
DKPA202270104 2022-03-15
PCT/EP2022/082950 WO2023094435A1 (en) 2021-11-23 2022-11-23 New tale protein scaffolds with improved on-target/off-target activity ratios

Publications (1)

Publication Number Publication Date
MX2024006051A true MX2024006051A (es) 2024-06-26

Family

ID=84487474

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024006051A MX2024006051A (es) 2021-11-23 2022-11-23 Nuevos andamios de proteinas tale con relaciones de actividad en objetivo/fuera de objetivo mejoradas.

Country Status (9)

Country Link
US (1) US20250002945A1 (https=)
EP (1) EP4437091A1 (https=)
JP (1) JP2024540639A (https=)
KR (1) KR20240110844A (https=)
AU (1) AU2022395500A1 (https=)
CA (1) CA3238700A1 (https=)
IL (1) IL312721A (https=)
MX (1) MX2024006051A (https=)
WO (1) WO2023094435A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4583890A1 (en) * 2022-09-09 2025-07-16 Iovance Biotherapeutics, Inc. Processes for generating til products using pd-1/tigit talen double knockdown
WO2025181336A1 (en) 2024-03-01 2025-09-04 Cellectis Sa Compositions and methods for hbb-editing in hspc
WO2025211767A1 (ko) * 2024-04-02 2025-10-09 재단법인 아산사회복지재단 핵산 결합 단백질 및 ssda를 포함하는 융합단백질 및 이의 용도
WO2026046724A1 (en) 2024-08-30 2026-03-05 Cellectis Sa Tale protein scaffolds involving fusions of monopartite and bipartite nls

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4921757A (en) 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
JPH0825869B2 (ja) 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤
US4911928A (en) 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US4917951A (en) 1987-07-28 1990-04-17 Micro-Pak, Inc. Lipid vesicles formed of surfactants and steroids
WO2011072246A2 (en) 2009-12-10 2011-06-16 Regents Of The University Of Minnesota Tal effector-mediated dna modification
CA3111953C (en) 2011-04-05 2023-10-24 Cellectis Method for the generation of compact tale-nucleases and uses thereof
EP2737066B1 (en) 2011-07-29 2017-11-08 Cellectis High throughput method for assembly and cloning polynucleotides comprising highly similar polynucleotidic modules
BR112014029417B1 (pt) 2012-05-25 2023-03-07 Cellectis Método ex vivo para a preparação de células t para imunoterapia
US10378007B2 (en) * 2012-09-03 2019-08-13 Cellectis Methods for modulating TAL specificity
ES2716867T3 (es) 2013-05-31 2019-06-17 Cellectis Sa Endonucleasa de asentamiento LAGLIDADG que escinde el gen de receptor de células T alfa y usos de la misma

Also Published As

Publication number Publication date
EP4437091A1 (en) 2024-10-02
JP2024540639A (ja) 2024-10-31
CA3238700A1 (en) 2022-11-23
IL312721A (en) 2024-07-01
KR20240110844A (ko) 2024-07-16
AU2022395500A1 (en) 2024-05-23
WO2023094435A1 (en) 2023-06-01
US20250002945A1 (en) 2025-01-02

Similar Documents

Publication Publication Date Title
MX2024006051A (es) Nuevos andamios de proteinas tale con relaciones de actividad en objetivo/fuera de objetivo mejoradas.
Heidorn et al. Synthetic biology in cyanobacteria: engineering and analyzing novel functions
BR112019012183A2 (pt) métodos de modificar o material genético de uma célula eucariótica e de um organismo, vetor de expressão de polinucleotídeo, e, célula procariótica.
CO2018006699A2 (es) Métodos escalables para producir un vector viral adenoasociado (aav) recombinante en un sistema de cultivo celular en suspensión sin suero adecuado para uso clínico
BR112013007862A2 (pt) ácidos nucleicos manipulados e métodos de uso dos mesmos.
MX2021006741A (es) Ingenieria del genoma humano guiada por acido ribonucleico.
AR117697A2 (es) Medios de cultivo celular
MX2012013037A (es) Composiciones de endorribonucleasa y metodos de uso de las mismas.
MX2020013384A (es) Compuestos de comarina sustituidos con amina exocíclica y sus usos como etiquetas fluorescentes.
EA201171018A1 (ru) Биореактор для культивирования клеток млекопитающих
PY2055454A (es) Polipéptidos que poseen actividad de beta-glucanasa y polinucleótidos que los codifican
IL287089B1 (en) Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias
BR112014029441A2 (pt) rna tendo como alvo dna; polinucleotídeo de dna; vetor de expressão recombinante; célula hospedeira geneticamente modificada in vitro; polipeptídeo de modificação dirigido a sítio variante; polipeptídeo de modificação dirigido a sítio quimérico; polinucleotídeo de rna; célula modificada geneticamente; organismo não humano transgênico cujo genoma compreende um transgene; composição; método de modificação específica de sítio de um dna de alvo; método de modulação de transcrição específica de sítio dentro de um dna de alvo; método de modificação específica de sítio em dna de alvo; método de promover clivagem e modificação específica de sítio de um dna de alvo em uma célula; método de produzir uma célula modificada geneticamente em um sujeito; método de modificar dna de alvo em uma célula modificada geneticamente; kit; kit para direcionar dna de alvo; método de modular seletivamente transcrição de um dna de alvo em uma célula hospedeira; ácido nucleico isolado; célula hospedeira modificada geneticamente; e biblioteca de ácidos nucleicos
BR112013002811A8 (pt) meios básicos simplificados para cultura celular pluripotente de humano
BR112016013400A2 (pt) métodos para modificar um genoma e para produzir um camundongo
BR112012017267A2 (pt) ácidos graxos de cadeia ramificada dispersos e produção biológica dos mesmos
RU2014149120A (ru) Способы и композиции для опосредованной нуклеазой направленной интеграции трансгенов
AR078544A1 (es) Procedimiento de cultivo de celulas de mamiferos para la produccion de proteinas
BR112019006388A2 (pt) enzimas modificadoras de ácido nucleico guiadas por rna e métodos de uso das mesmas
MX2021014054A (es) Metodos y celulas para la produccion microbiana de fitocannabinoides y precursores de fitocannabinoides.
AR086995A1 (es) Metodos y composiciones para producir plantas con esterilidad masculina
MX354267B (es) Nucléosidos, nucleótidos, y ácidos nucleicos modificados, y usos de los mismos.
AR088140A1 (es) Sonda y metodo para direccionar acidos nucleicos
PY2110525A (es) Polipéptidos con actividad de alfa amilasa y polinucleótidos que los codifican
UY35019A (es) Loci de performance de fad3 y proteínas de unión específicas de un sitio objetivo correspondiente capaces de inducir rupturas direccionadas